Form 4: Establishment Labs Director Acquires Shares in Lieu of Cash Retainer

Sentiment:

SEC Form 4 Filing


Director Nicholas Sheridan Lewin acquired 612 common shares of Establishment Labs Holdings Inc. in lieu of a quarterly cash retainer payment on March 31, 2025.

Summary

  • On March 31, 2025, Nicholas Sheridan Lewin, a director of Establishment Labs Holdings Inc., acquired 612 common shares.
  • The shares were acquired in lieu of a quarterly cash retainer payment, as per the company's Outside Director Compensation Policy.
  • The price per share was $40.81.
  • Following the transaction, Lewin directly owns 1,071,925 common shares.
  • Lewin's spouse indirectly owns 14,190 shares.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a routine transaction (shares in lieu of cash). The director's confidence in taking shares is a slight positive.

Positives

  • The director's decision to take shares instead of cash may signal confidence in the company's future performance.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's value and future prospects. A director choosing to receive shares instead of cash could be interpreted as a positive signal.

Stakeholder Impact

  • The transaction could have a minor positive impact on shareholder sentiment.

Key Dates

DateDescription
03/31/2025Date of transaction: Director acquired shares in lieu of cash retainer.
04/01/2025Date of signature by power of attorney.

Keywords

Establishment Labs, Director, Share Acquisition, Form 4, Equity, ESTA, Nicholas Sheridan Lewin, Insider Transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.